ID   LGI3_HUMAN              Reviewed;         548 AA.
AC   Q8N145; A5PLP2; Q86TL4; Q8N296;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   28-JUN-2023, entry version 164.
DE   RecName: Full=Leucine-rich repeat LGI family member 3;
DE   AltName: Full=LGI1-like protein 4;
DE   AltName: Full=Leucine-rich glioma-inactivated protein 3;
DE   Flags: Precursor;
GN   Name=LGI3; Synonyms=LGIL4; ORFNames=UNQ8190/PRO23199;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=12023020; DOI=10.1016/s0014-5793(02)02713-8;
RA   Gu W., Wevers A., Schroder H., Grzeschik K.H., Derst C., Brodtkorb E.,
RA   de Vos R., Steinlein O.K.;
RT   "The LGI1 gene involved in lateral temporal lobe epilepsy belongs to a new
RT   subfamily of leucine-rich repeat proteins.";
RL   FEBS Lett. 519:71-76(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12095917; DOI=10.1093/hmg/11.15.1757;
RA   Scheel H., Tomiuk S., Hofmann K.;
RT   "A common protein interaction domain links two recently identified epilepsy
RT   genes.";
RL   Hum. Mol. Genet. 11:1757-1762(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12217514; DOI=10.1016/s0968-0004(02)02163-1;
RA   Staub E., Perez-Tur J., Siebert R., Nobile C., Moschonas N.K., Deloukas P.,
RA   Hinzmann B.;
RT   "The novel EPTP repeat defines a superfamily of proteins implicated in
RT   epileptic disorders.";
RL   Trends Biochem. Sci. 27:441-444(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 131-548 (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   VARIANTS IDDMDS 112-SER--ALA-548 DEL; HIS-141 AND ASN-331, CHARACTERIZATION
RP   OF VARIANT IDDMDS HIS-141, INVOLVEMENT IN IDDMDS, AND SUBCELLULAR LOCATION.
RX   PubMed=35948005; DOI=10.1016/j.ajhg.2022.07.006;
RA   Marafi D., Kozar N., Duan R., Bradley S., Yokochi K., Al Mutairi F.,
RA   Saadi N.W., Whalen S., Brunet T., Kotzaeridou U., Choukair D., Keren B.,
RA   Nava C., Kato M., Arai H., Froukh T., Faqeih E.A., Al Asmari A.M.,
RA   Saleh M.M., Pinto Vairo F., Pichurin P.N., Klee E.W., Schmitz C.T.,
RA   Grochowski C.M., Mitani T., Herman I., Calame D.G., Fatih J.M., Du H.,
RA   Coban-Akdemir Z., Pehlivan D., Jhangiani S.N., Gibbs R.A., Miyatake S.,
RA   Matsumoto N., Wagstaff L.J., Posey J.E., Lupski J.R., Meijer D., Wagner M.;
RT   "A reverse genetics and genomics approach to gene paralog function and
RT   disease: Myokymia and the juxtaparanode.";
RL   Am. J. Hum. Genet. 109:1713-1723(2022).
CC   -!- FUNCTION: May participate in the regulation of neuronal exocytosis.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with STX1A. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:35948005}.
CC       Cytoplasmic vesicle, secretory vesicle, synaptic vesicle
CC       {ECO:0000250|UniProtKB:Q8K406}. Synapse, synaptosome
CC       {ECO:0000250|UniProtKB:Q8K406}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q8K406}. Note=Found in the synaptosomal membrane
CC       fraction. Within peripheral myelinated axons, LGI3 is highly expressed
CC       at the juxtaparanodal membrane and colocalizes with the voltage-gated
CC       potassium channels Kv1.1 (KCNA1) and Kv1.2 (KCNA2), and with CNTNAP2,
CC       DLG4, ADAM22 and ADAM23 (By similarity).
CC       {ECO:0000250|UniProtKB:Q8K406}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N145-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N145-2; Sequence=VSP_056297;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in brain and
CC       lung. {ECO:0000269|PubMed:12023020}.
CC   -!- DISEASE: Intellectual developmental disorder with muscle tone
CC       abnormalities and distal skeletal defects (IDDMDS) [MIM:620007]: An
CC       autosomal recessive disorder characterized by global developmental
CC       delay, intellectual disability, distal deformities with diminished
CC       reflexes, visible facial myokymia, and distinctive electromyographic
CC       features suggestive of motor nerve instability.
CC       {ECO:0000269|PubMed:35948005}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03553.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF467956; AAM49554.1; -; mRNA.
DR   EMBL; AJ487961; CAD32308.1; -; mRNA.
DR   EMBL; AJ487518; CAD31786.1; -; mRNA.
DR   EMBL; AY358116; AAQ88483.1; -; mRNA.
DR   EMBL; AK090946; BAC03553.1; ALT_INIT; mRNA.
DR   EMBL; AC105206; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC042542; AAH42542.1; -; mRNA.
DR   EMBL; BC142997; AAI42998.1; -; mRNA.
DR   CCDS; CCDS6025.1; -. [Q8N145-1]
DR   RefSeq; NP_644807.1; NM_139278.2. [Q8N145-1]
DR   AlphaFoldDB; Q8N145; -.
DR   SMR; Q8N145; -.
DR   BioGRID; 128454; 2.
DR   STRING; 9606.ENSP00000302297; -.
DR   GlyCosmos; Q8N145; 2 sites, No reported glycans.
DR   GlyGen; Q8N145; 2 sites.
DR   iPTMnet; Q8N145; -.
DR   PhosphoSitePlus; Q8N145; -.
DR   BioMuta; LGI3; -.
DR   DMDM; 32469742; -.
DR   MassIVE; Q8N145; -.
DR   PaxDb; Q8N145; -.
DR   PeptideAtlas; Q8N145; -.
DR   ProteomicsDB; 71555; -. [Q8N145-1]
DR   ProteomicsDB; 749; -.
DR   Antibodypedia; 22532; 154 antibodies from 25 providers.
DR   DNASU; 203190; -.
DR   Ensembl; ENST00000306317.7; ENSP00000302297.2; ENSG00000168481.9. [Q8N145-1]
DR   Ensembl; ENST00000424267.6; ENSP00000399121.2; ENSG00000168481.9. [Q8N145-2]
DR   GeneID; 203190; -.
DR   KEGG; hsa:203190; -.
DR   MANE-Select; ENST00000306317.7; ENSP00000302297.2; NM_139278.4; NP_644807.1.
DR   UCSC; uc003xav.4; human. [Q8N145-1]
DR   AGR; HGNC:18711; -.
DR   CTD; 203190; -.
DR   DisGeNET; 203190; -.
DR   GeneCards; LGI3; -.
DR   HGNC; HGNC:18711; LGI3.
DR   HPA; ENSG00000168481; Tissue enriched (brain).
DR   MalaCards; LGI3; -.
DR   MIM; 608302; gene.
DR   MIM; 620007; phenotype.
DR   neXtProt; NX_Q8N145; -.
DR   OpenTargets; ENSG00000168481; -.
DR   PharmGKB; PA38655; -.
DR   VEuPathDB; HostDB:ENSG00000168481; -.
DR   eggNOG; ENOG502QSAR; Eukaryota.
DR   GeneTree; ENSGT00940000160296; -.
DR   HOGENOM; CLU_036403_0_0_1; -.
DR   InParanoid; Q8N145; -.
DR   OMA; EGDWFFA; -.
DR   OrthoDB; 4083661at2759; -.
DR   PhylomeDB; Q8N145; -.
DR   TreeFam; TF333155; -.
DR   PathwayCommons; Q8N145; -.
DR   Reactome; R-HSA-5682910; LGI-ADAM interactions.
DR   BioGRID-ORCS; 203190; 15 hits in 1141 CRISPR screens.
DR   ChiTaRS; LGI3; human.
DR   GenomeRNAi; 203190; -.
DR   Pharos; Q8N145; Tbio.
DR   PRO; PR:Q8N145; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q8N145; protein.
DR   Bgee; ENSG00000168481; Expressed in C1 segment of cervical spinal cord and 123 other tissues.
DR   ExpressionAtlas; Q8N145; baseline and differential.
DR   Genevisible; Q8N145; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0044224; C:juxtaparanode region of axon; ISS:UniProtKB.
DR   GO; GO:0008021; C:synaptic vesicle; IBA:GO_Central.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0017157; P:regulation of exocytosis; IBA:GO_Central.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR009039; EAR.
DR   InterPro; IPR005492; EPTP.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR011041; Quinoprot_gluc/sorb_DH.
DR   PANTHER; PTHR24367:SF10; LEUCINE-RICH REPEAT LGI FAMILY MEMBER 3; 1.
DR   PANTHER; PTHR24367; LEUCINE-RICH REPEAT-CONTAINING PROTEIN; 1.
DR   Pfam; PF03736; EPTP; 7.
DR   Pfam; PF13855; LRR_8; 1.
DR   SMART; SM00369; LRR_TYP; 3.
DR   SMART; SM00082; LRRCT; 1.
DR   SUPFAM; SSF52058; L domain-like; 1.
DR   SUPFAM; SSF50952; Soluble quinoprotein glucose dehydrogenase; 1.
DR   PROSITE; PS50912; EAR; 7.
DR   PROSITE; PS51450; LRR; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Cytoplasmic vesicle;
KW   Disease variant; Exocytosis; Glycoprotein; Intellectual disability;
KW   Leucine-rich repeat; Reference proteome; Repeat; Secreted; Signal; Synapse;
KW   Synaptosome.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..548
FT                   /note="Leucine-rich repeat LGI family member 3"
FT                   /id="PRO_0000017710"
FT   DOMAIN          31..64
FT                   /note="LRRNT"
FT   REPEAT          89..110
FT                   /note="LRR 1"
FT   REPEAT          113..134
FT                   /note="LRR 2"
FT   REPEAT          137..158
FT                   /note="LRR 3"
FT   DOMAIN          170..220
FT                   /note="LRRCT"
FT   REPEAT          222..264
FT                   /note="EAR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          268..310
FT                   /note="EAR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          314..361
FT                   /note="EAR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          363..406
FT                   /note="EAR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          410..453
FT                   /note="EAR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          455..497
FT                   /note="EAR 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          501..543
FT                   /note="EAR 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   CARBOHYD        189
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        311
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         117..140
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_056297"
FT   VARIANT         112..548
FT                   /note="Missing (in IDDMDS)"
FT                   /evidence="ECO:0000269|PubMed:35948005"
FT                   /id="VAR_087683"
FT   VARIANT         141
FT                   /note="L -> H (in IDDMDS; severely reduced secretion due to
FT                   retention of the mutant in the Golgi apparatus)"
FT                   /evidence="ECO:0000269|PubMed:35948005"
FT                   /id="VAR_087684"
FT   VARIANT         331
FT                   /note="D -> N (in IDDMDS; severely reduced secretion due to
FT                   retention of the mutant in the Golgi apparatus)"
FT                   /evidence="ECO:0000269|PubMed:35948005"
FT                   /id="VAR_087685"
FT   VARIANT         524
FT                   /note="A -> T (in dbSNP:rs34112456)"
FT                   /id="VAR_053488"
FT   CONFLICT        509
FT                   /note="A -> V (in Ref. 4; AAQ88483)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   548 AA;  61704 MW;  32FE6EABA184E47B CRC64;
     MAGLRARGGP GPGLLALSAL GFCLMLQVSA KRPPKTPPCP PSCSCTRDTA FCVDSKAVPR
     NLPSEVISLT LVNAAFSEIQ DGAFSHLPLL QFLLLNSNKF TLIGDNAFTG LSHLQYLFIE
     NNDIWALSKF TFRGLKSLTH LSLANNNLQT LPRDIFRPLD ILNDLDLRGN SLNCDCKVKW
     LVEWLAHTNT TVAPIYCASP PRFQEHKVQD LPLREFDCIT TDFVLYQTLA FPAVSAEPFL
     YSSDLYLALA QPGVSACTIL KWDYVERQLR DYDRIPAPSA VHCKPMVVDS QLYVVVAQLF
     GGSYIYHWDP NTTRFTRLQD IDPQRVRKPN DLEAFRIDGD WYFAVADSSK AGATSLYRWH
     QNGFYSHQAL HPWHRDTDLE FVDGEGKPRL IVSSSSQAPV IYQWSRTQKQ FVAQGEVTQV
     PDAQAVKHFR AGRDSYLCLS RYIGDSKILR WEGTRFSEVQ ALPSRGSLAL QPFLVGGRRY
     LALGSDFSFT QIYQWDEGRQ KFVRFQELAV QAPRAFCYMP AGDAQLLLAP SFKGQTLVYR
     HIVVDLSA
//
